🔴 Neurosense Therapeutics is trading 5% down today amid a broader market pullback

Neurosense Therapeutics is trading 5% down at $0.41 amid a broader market pullback.

• The S&P 500 was down 0.61% and the Nasdaq Composite was down 1.37% on August 18, 2026.
• No new company-specific announcement was identified during the session.
• Recent negative sentiment has centered on delayed financing for the Phase 3 PARAGON ALS study and potential reverse-split authorization, with those updates released August 13–14.